Clinical trials: Gout; Hyperuricemia

Hyperuricemia

Study of FYU-981 in Hyperuricemia With or Without Gout

• Completed
• Age: 20 to 64 years
• Phase 2
• Pill or oral medicine

The purpose of this study is exploratory investigation of safety and efficacy (dose response and optimal dose according to the percent reduction from baseline in serum urate level at the final visit) of FYU-981 administered…

Trial name

NCT02344862

Testing

FYU-981 High dose, (Oral daily dosing for 8 weeks), FYU-981 Middle dose, (Oral daily dosing for 8 weeks), FYU-981 Low dose, (Oral daily dosing for 8 weeks)

Where

Japan

Volunteers

80 people

Sponsor

Fuji Yakuhin Co., Ltd.